As GLP-1 receptor agonists and dual incretin agents become more common in treating obesity and type 2 diabetes, primary care ...

Oral GLP-1s for obesity can differ from injectables — including in their effectiveness and dosing. Here's why pills aren’t ...

Influencers, content creators and celebrities across social media platforms are touting the benefits of GLP-1 drugs, but many of them aren’t taking them in the same dosages as most weight loss ...

As cash-pay consumers compare GLP-1 telehealth programs in 2026, this Lttl review examines the brand-stated "same price at every dose" model, compounded semaglutide and tirzepatide options, ...

Corrections: This story was updated to clarify the findings of clinical trials and out-of-pocket cost information. As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

“As a pharmacist, I've seen social media become a major source of health information for many patients,” says Sue Ojageer, a pharmacist and founder of the concierge health practice PharmaSue. “While ...